656 related articles for article (PubMed ID: 27919360)
1. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
[TBL] [Abstract][Full Text] [Related]
2. Relationship of epicardial fat thickness and nonalcoholic fatty liver disease to coronary artery calcification: From the CAESAR study.
Kim BJ; Cheong ES; Kang JG; Kim BS; Kang JH
J Clin Lipidol; 2016; 10(3):619-626.e1. PubMed ID: 27206950
[TBL] [Abstract][Full Text] [Related]
3. The Influence of Epicardial Fat and Nonalcoholic Fatty Liver Disease on Heart Rate Recovery in Metabolic Syndrome.
Cho KI; Jo EA; Cho SH; Kim BH
Metab Syndr Relat Disord; 2017 Jun; 15(5):226-232. PubMed ID: 28346857
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome, fatty liver, and artificial intelligence-based epicardial adipose tissue measures predict long-term risk of cardiac events: a prospective study.
Lin A; Wong ND; Razipour A; McElhinney PA; Commandeur F; Cadet SJ; Gransar H; Chen X; Cantu S; Miller RJH; Nerlekar N; Wong DTL; Slomka PJ; Rozanski A; Tamarappoo BK; Berman DS; Dey D
Cardiovasc Diabetol; 2021 Jan; 20(1):27. PubMed ID: 33514365
[TBL] [Abstract][Full Text] [Related]
5. Relationship of Echocardiographic Epicardial Fat Thickness and Epicardial Fat Volume by Computed Tomography with Coronary Artery Calcification: Data from the CAESAR Study.
Kim BJ; Kang JG; Lee SH; Lee JY; Sung KC; Kim BS; Kang JH
Arch Med Res; 2017 May; 48(4):352-359. PubMed ID: 28916241
[TBL] [Abstract][Full Text] [Related]
6. Relation of nonalcoholic fatty liver disease to the metabolic syndrome: the Multi-Ethnic Study of Atherosclerosis.
Zeb I; Katz R; Nasir K; Ding J; Rezaeian P; Budoff MJ
J Cardiovasc Comput Tomogr; 2013; 7(5):311-8. PubMed ID: 24268118
[TBL] [Abstract][Full Text] [Related]
7. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
[TBL] [Abstract][Full Text] [Related]
9. Epicardial Fat in Nonalcoholic Fatty Liver Disease: Properties and Relationships With Metabolic Factors, Cardiac Structure, and Cardiac Function.
Psychari SN; Rekleiti N; Papaioannou N; Varhalama E; Drakoulis C; Apostolou TS; Iliodromitis EK
Angiology; 2016 Jan; 67(1):41-8. PubMed ID: 25818101
[TBL] [Abstract][Full Text] [Related]
10. Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study.
Weinstein G; Zelber-Sagi S; Preis SR; Beiser AS; DeCarli C; Speliotes EK; Satizabal CL; Vasan RS; Seshadri S
JAMA Neurol; 2018 Jan; 75(1):97-104. PubMed ID: 29159396
[TBL] [Abstract][Full Text] [Related]
11. Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link?
Russo GI; Cimino S; Castelli T; Favilla V; Gacci M; Carini M; Condorelli RA; La Vignera S; Calogero AE; Motta F; Puzzo L; Caltabiano R; Morgia G
Prostate; 2016 Dec; 76(16):1528-1535. PubMed ID: 27458062
[TBL] [Abstract][Full Text] [Related]
12. The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).
Al Rifai M; Silverman MG; Nasir K; Budoff MJ; Blankstein R; Szklo M; Katz R; Blumenthal RS; Blaha MJ
Atherosclerosis; 2015 Apr; 239(2):629-33. PubMed ID: 25683387
[TBL] [Abstract][Full Text] [Related]
13. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
[TBL] [Abstract][Full Text] [Related]
14. The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification.
Cho YK; Kang YM; Yoo JH; Lee J; Lee SE; Yang DH; Kang JW; Park JY; Jung CH; Kim HK; Lee WJ
Sci Rep; 2018 Aug; 8(1):12004. PubMed ID: 30104707
[TBL] [Abstract][Full Text] [Related]
15. The newly proposed Metabolic Score for Visceral Fat is a reliable tool for identifying non-alcoholic fatty liver disease, requiring attention to age-specific effects in both sexes.
Kuang M; Qiu J; Li D; Hu C; Zhang S; Sheng G; Zou Y
Front Endocrinol (Lausanne); 2023; 14():1281524. PubMed ID: 38089634
[TBL] [Abstract][Full Text] [Related]
16. Meta-Analysis of Non-Alcoholic Fatty Liver Disease and Electromechanical Reconstruction of Myocardium.
Tretyakova VA; Zhernakova NI; Arisheva OS; Garmash IV; Tretyakov A; Gerasimov NI; Ermilov OV
Arch Razi Inst; 2022 Feb; 77(1):135-140. PubMed ID: 35891721
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic fatty liver disease associated with metabolic syndrome: Influence of liver fibrosis stages on characteristics of very low-density lipoproteins.
Lucero D; Miksztowicz V; Gualano G; Longo C; Landeira G; Álvarez E; Zago V; Brites F; Berg G; Fassio E; Schreier L
Clin Chim Acta; 2017 Oct; 473():1-8. PubMed ID: 28802640
[TBL] [Abstract][Full Text] [Related]
18. Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population.
Zhang Y; Zhang T; Zhang C; Tang F; Zhong N; Li H; Song X; Lin H; Liu Y; Xue F
BMJ Open; 2015 Sep; 5(9):e008204. PubMed ID: 26395497
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of using epicardial fat measurement on screening low-dose chest CT for the prediction of metabolic syndrome: A cross-validation study.
Kim HJ; Lee H; Lee B; Lee JW; Shin KE; Suh J; Park HW; Kim JA
Medicine (Baltimore); 2019 Feb; 98(7):e14601. PubMed ID: 30762814
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Nonalcoholic Fatty Liver Disease in Familial Mediterranean Fever.
Tasliyurt T; Gokce E; Sahin S; Aslan AB; Demir AK; Uzun S; Kutluturk F
Endocr Metab Immune Disord Drug Targets; 2020; 20(6):952-958. PubMed ID: 32077835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
